HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

2-[4-(4-Amino-2-methoxy-phenyl)-piperidin-1-yl]-acetamide → Trifluoroacetic acid

HRID 1262144
Print

Reaction equation

HRID 1262144 reaction equation
[CH3:1][O:2][C:3]1[CH:8]=[C:7]([NH:9][C:10]2[N:15]=[CH:14][C:13]3=[CH:16][CH:17]=[C:18]([C:19]4[CH:20]=[N:21][C:22]([O:25][CH3:26])=[CH:23][CH:24]=4)[N:12]3[N:11]=2)[CH:6]=[CH:5][C:4]=1[CH:27]1[CH2:32][CH2:31][N:30]([CH2:33][C:34]([NH2:36])=[O:35])[CH2:29][CH2:28]1.COC1N=CC(C2N3C(C=NC(OS([C:58]([F:61])([F:60])[F:59])(=O)=O)=N3)=CC=2)=CC=1.NC1C=CC(C2CCN(CC(N)=O)CC2)=C([O:79][CH3:80])C=1>>[CH3:1][O:2][C:3]1[CH:8]=[C:7]([NH:9][C:10]2[N:15]=[CH:14][C:13]3=[CH:16][CH:17]=[C:18]([C:19]4[CH:20]=[N:21][C:22]([O:25][CH3:26])=[CH:23][CH:24]=4)[N:12]3[N:11]=2)[CH:6]=[CH:5][C:4]=1[CH:27]1[CH2:32][CH2:31][N:30]([CH2:33][C:34]([NH2:36])=[O:35])[CH2:29][CH2:28]1.[C:80]([OH:79])([C:58]([F:59])([F:60])[F:61])=[O:2]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

5

Reactant 3

HCID 667119832-[4-(4-Amino-2-methoxy-phenyl)-piperidin-1-yl]-acetamideHCID 667123102-(4-{2-Methoxy-4-[7-(6-methoxy-pyridin-3-yl)-pyrrolo[2,1-f][1,2,4]triazin-2-ylamino]-phenyl}-piperidin-1-yl)-acetamideHCID 86661684Trifluoro-methanesulfonic acid 7-(6-methoxy-pyridin-3-yl)-pyrrolo[2,1-f][1,2,4]triazin-2-yl ester

Product 2

HCID 6422Trifluoroacetic acidYield 33%
HCID 66712310
2-(4-{2-Methoxy-4-[7-(6-methoxy-pyridin-3-yl)-pyrrolo[2,1-f][1,2,4]triazin-2-ylamino]-phenyl}-piperidin-1-yl)-acetamide

Procedure

2-(4-{2-Methoxy-4-[7-(6-methoxy-pyridin-3-yl)-pyrrolo[2,1-f][1,2,4]triazin-2-ylamino]-phenyl}-piperidin-1-yl)-acetamide. Trifluoro-methanesulfonic acid 7-(6-methoxy-pyridin-3-yl)-pyrrolo[2,1-f][1,2,4]triazin-2-yl ester (0.138 g, 0.369 mmol; and 2-[4-(4-Amino-2-methoxy-phenyl)-piperidin-1-yl]-acetamide (0.121 g, 0.461 mmol) were reacted in an analogous manner to Example 908D at room temp for 72 h. The reaction mixture was concentrated, taken up in EtOAc, and washed with brine. The EtOAc layer was dried, filtered over MgSO4, and concentrated. The resulting residue was purified by Gilson RP-HPLC and lyophilized to afford title compound as a TFA salt (59 mg, 33%). LCMS=488.0 (M+H), HPLC rt=2.329, purity=99%. 1H NMR (400 MHz, (D3C)2SO, δ, ppm): 9.53 (bs, 1H), 9.47 (s, 1H), 9.02 (s, 1H), 9.00 (d, J=8.2 Hz, 1H), 8.40 (dd, J=8.7 Hz, 2.3 Hz, 1H), 7.98 (s, 1H), 7.71 (s, 1H), 7.46 (s, 1H), 7.24 (d, J=8.5 Hz, 1H), 7.17 (d, J=4.9 Hz, 1H), 7.04 (d, J=8.3 Hz, 1H0, 6.97 (d, J=4.7 Hz, 1H), 6.93 (s, 1H), 3.93 (s, 3H), 3.89 (m, 2H), 3.70 (s, 3H), 3.54 (d, J=11.7 Hz, 2H), 3.23-3.05 (m, 3H), 2.05-1.95 (m, 2H), 1.85-1.88 (m, 2H).

Workup

  1. concentrationThe reaction mixture was concentrated
  2. washwashed with brine
  3. dry with materialThe EtOAc layer was dried
  4. filtrationfiltered over MgSO4
  5. concentrationconcentrated
  6. customThe resulting residue was purified by Gilson RP-HPLC

Sources & evidence

ORD record
ord-372c9a3157264ba8a23d92f08edb7e4c
Source dataset
uspto-grants-2013_06
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08471005B2

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes